These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22252982)

  • 1. Solid-state vitrification of crystalline griseofulvin by mechanical milling.
    Willart JF; Carpentier L; Danède F; Descamps M
    J Pharm Sci; 2012 Apr; 101(4):1570-7. PubMed ID: 22252982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
    Feng T; Bates S; Carvajal MT
    Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state amorphization of linaprazan by mechanical milling and evidence of polymorphism.
    Willart JF; Durand M; Briggner LE; Marx A; Danède F; Descamps M
    J Pharm Sci; 2013 Jul; 102(7):2214-20. PubMed ID: 23686607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on the Physical State Reached by an Active Pharmaceutical Ingredient upon High-Energy Milling.
    Schammé B; Monnier X; Couvrat N; Delbreilh L; Dupray V; Dargent É; Coquerel G
    J Phys Chem B; 2017 May; 121(19):5142-5150. PubMed ID: 28430440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of milling-induced disorder of two pharmaceutical compounds.
    Otte A; Carvajal MT
    J Pharm Sci; 2011 May; 100(5):1793-804. PubMed ID: 21374615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
    Trasi NS; Boerrigter SX; Byrn SR
    Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin.
    Feng T; Pinal R; Carvajal MT
    J Pharm Sci; 2008 Aug; 97(8):3207-21. PubMed ID: 17990307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
    Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
    J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Milling to Explore Physical States: The Amorphous and Polymorphic Forms of Sulindac.
    Latreche M; Willart JF; Guerain M; Hédoux A; Danède F
    J Pharm Sci; 2019 Aug; 108(8):2635-2642. PubMed ID: 30905700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Dudognon E; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2016 Feb; 499(1-2):67-73. PubMed ID: 26707413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
    Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor.
    Jarmer DJ; Lengsfeld CS; Anseth KS; Randolph TW
    J Pharm Sci; 2005 Dec; 94(12):2688-702. PubMed ID: 16258994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactulose: A Model System to Investigate Solid State Amorphization Induced by Milling.
    Ngono F; Willart JF; Cuello G; Jimenez-Ruiz M; Affouard F
    J Pharm Sci; 2019 Feb; 108(2):880-887. PubMed ID: 30244010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the polymorphism of griseofulvin: identification of two additional polymorphs.
    Mahieu A; Willart JF; Dudognon E; Eddleston MD; Jones W; Danède F; Descamps M
    J Pharm Sci; 2013 Feb; 102(2):462-8. PubMed ID: 23132509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
    Branham ML; Moyo T; Govender T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):194-202. PubMed ID: 21906676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphization of different furosemide polymorphic forms during ball milling: Tracking solid-to-solid phase transformations.
    Wang M; Gong J; Rades T; Martins ICB
    Int J Pharm; 2023 Dec; 648():123573. PubMed ID: 37931725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.